TY  - GEN
AU  - Ko,Andrew H
AU  - Murphy,Patrick B
AU  - Peyton,James D
AU  - Shipley,Dianna L
AU  - Al-Hazzouri,Ahmed
AU  - Rodriguez,Francisco A
AU  - Womack,Mark S
AU  - Xiong,Henry Q
AU  - Waterhouse,David M
AU  - Tempero,Margaret A
AU  - Guo,Shuangli
AU  - Lane,Cassie M
AU  - Earwood,Chris
AU  - DeBusk,Laura M
AU  - Bendell,Johanna C
TI  - A Randomized, Double-Blinded, Phase II Trial of Gemcitabine and Nab-Paclitaxel Plus Apatorsen or Placebo in Patients with Metastatic Pancreatic Cancer: The RAINIER Trial
SN  - 1549-490X
PY  - 2018///0723
KW  - Adult
KW  - Aged
KW  - Albumins
KW  - administration & dosage
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Deoxycytidine
KW  - Disease-Free Survival
KW  - Female
KW  - HSP27 Heat-Shock Proteins
KW  - antagonists & inhibitors
KW  - Humans
KW  - Kaplan-Meier Estimate
KW  - Male
KW  - Middle Aged
KW  - Oligonucleotides, Antisense
KW  - Paclitaxel
KW  - Pancreatic Neoplasms
KW  - blood
KW  - Prognosis
KW  - Treatment Outcome
KW  - Gemcitabine
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1634/theoncologist.2017-0066
ER  -